A CBS17 news report says antibody treatment for high-risk patients fighting COVID-19 is now available in central North Carolina, but there is a limited supply of the medication. David Wohl, MD, professor in the division of infectious diseases, told CBS17 that it is being prioritized for people who have the greatest risk of getting really sick.
Read the report here.